Increased exposure to hepatitis B virus infection in HIV-positive South African antenatal women

International Journal of STD and AIDS

Volumn 18, Issue 3, 2007, Pages 152-156

  Burnett, R J ^a,d   Ngobeni, J M ^a   Francois G ^b   Hoosen, A A ^a   Leroux Roels, G ^c   Meheus, A ^b   Mphahlele, M J ^a  

^a SEFAKO MAKGATHO HEALTH SCIENCES UNIVERSITY   (South Africa)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

^d UNIVERSITY OF LIMPOPO   (South Africa)

Author keywords

HBV; HBV HIV co infection; HIV; South Africa; Sub Saharan Africa

Indexed keywords

DNA; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; SEROLOGY; SOUTH AFRICA; VIRUS DETECTION; AFRICA SOUTH OF THE SAHARA; BLOOD; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; HUMAN IMMUNODEFICIENCY VIRUS; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDY; VIROLOGY;

AFRICA SOUTH OF THE SAHARA; CASE-CONTROL STUDIES; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HIV; HIV INFECTIONS; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDIES; SOUTH AFRICA;

EID: 34547570595     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/095646207780132523     Document Type: Article

References (39)

1. Ayoola EA. Viral hepatitis in Africa In: Zuckerman AJ, ed. Viral Hepatitis and Liver Disease. New York : Alan R Liss, 1988;161-9
2. Kew MC. Progress towards the comprehensive control of hepatitis B in Africa: a view from South Africa. Gut 1996;38(Suppl 2):S31-6
3. Kiire CF. The epidemiology and prophylaxis of hepatitis B in sub-Saharan Africa: a view from tropical and subtropical Africa. Gut 1996;38(Suppl 2):S5-12
4. Mphahlele MJ, François G, Kew MC, et al. Epidemiology and control of hepatitis B: implications for eastern and southern Africa. Southern Afr J Epidemiol Infect 2002;17:12-17
5. Burnett RJ, François G, Kew MC, et al. Hepatitis B virus and human immunodeficiency virus co-infection in sub-Saharan Africa: a call for further investigation. Liver Int 2005;25:201-13
6. Davis LG, Weber DJ, Lemon SM. Horizontal transmission of hepatitis B virus. Lancet 1989;1:889-93
7. Taylor PE, Stevens CE, de Cordoba SR, et al. Hepatitis B virus and human immunodeficiency virus: possible interactions In: Zuckerman AJ, ed. Viral Hepatitis and Liver Disease. New York: Alan R Liss, 1988;198-200
8. Hess G, Rossol S, Voth R, et al. Modification of the immune response against hepatitis B virus by the human immunodeficiency virus. Rheumatol Int 1989;9:175-9
9. Rogers AS, Lindsey JC, Futterman DC, et al. Serologic examination of hepatitis B infection and immunization in HIV-positive youth and associated risks. The Pediatric AIDS Clinical Trials Group Protocol 220 Team. AIDS Patient Care STDS 2000;14:651-7
10. Herrero Martinez E. Hepatitis B and hepatitis C co-infection in patients with HIV. Rev Med Virol 2001;11:253-70
11. Scharschmidt BF, Held MJ, Hollander HH, et al. Hepatitis B in patients with HIV infection: relationship to AIDS and patient survival. Ann Intern Med 1992;117:837-8
12. Horvath J, Raffanti SP. Clinical aspects of the interactions between human immunodeficiency virus and the hepatotropic viruses. Clin Infect Dis 1994;18:339-47
13. Bodsworth NJ, Cooper DA, Donovan B. The influence of human immunodeficiency virus type 1 infection on the development of the hepatitis B virus carrier state. J Infect Dis 1991;163:1138-40
14. Hadler SC, Judson FN, O'Malley PM, et al. Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodeficiency virus infection. J Infect Dis 1991;163:454-9
15. Sinicco A, Raiteri R, Sciandra M, et al. Coinfection and superinfection of hepatitis B virus in patients infected with human immunodeficiency virus: no evidence of faster progression to AIDS. Scand J Infect Dis 1997;29:111-15
16. Gilson RJC, Tedder RS, Weller IVD. Hepatitis B: reactivation or reinfection associated with HIV-1 infection. Lancet 1989;2:1330
17. Vento S, Di Perri G, Luzzati R, et al. Clinical reactivation of hepatitis B in anti-HBs-positive patients with AIDS. Lancet 1989;1:332-3
18. Matee MIN, Lyamuya EF, Mbena EC, et al. Prevalence of transfusion-associated viral infections and syphilis among blood donors in Muhimbili Medical Centre, Dar es Salaam, Tanzania. East Afr Med J 1999;76:167-71
19. Lodenyo H, Schoub B, Ally R, et al. Hepatitis B and C virus infections and liver function in AIDS patients at Chris Hani Baragwanath Hospital, Johannesburg. East Afr Med J 2000;77:13-15
20. Shao JF, Haukenes G, Yangi E, et al. Association of hepatitis B and human immunodeficiency virus infections in Tanzanian population groups. Eur J Clin Microbiol Infect Dis 1993;12:62-4
21. Nacro B, Dao B, Dahourou H. HBs antigen in children with suspicion of HIV infection. J Trop Pediatr 2001;47:303-4
22. ter Meulen J, Wittkowski KM, Kidenya JJ, et al. Evaluation of seroepidemiological associations between HIV-infection, hepatitis B and other sexually transmitted diseases in African patients. Eur J Epidemiol 1989;5:158-63
23. Nakwagala FN, Kagimu MM. Hepatitis B virus and HIV infections among patients in Mulago hospital. East Afr Med J. 2002;79:68-72
24. Candotti D, Mundy C, Kadewele G, et al. Serological and molecular screening for viruses in blood donors from Ntcheu, Malawi: high prevalence of HIV-1 subtype C and of markers of hepatitis B and C viruses. J Med Virol 2001;65:1-5
25. Kashala O, Mubikayi L, Kayembe K, et al. Hepatitis B virus activation among Central Africans infected with human immunodeficiency virus (HIV) type I: Pre-s2 antigen is predominantly expressed in HIV infection. J Infect Dis 1994;169:628-32
26. Menendez C, Sanchez-Tapias JM, Kahigwa E, et al. Prevalence and mother-to-infant transmission of hepatitis viruses B, C, and E in Southern Tanzania. J Med Virol 1999;58:215-20
27. Pawlotsky J, Bélec L, Grésenguet G, et al. High prevalence of hepatitis B, C, and E markers in young sexually active adults from the Central African Republic. J Med Virol 1995;46:269-73
28. Ogutu EO, Amayo EO, Okoth F, et al. The prevalence of hepatitis B surface antigen (HBsAg), anti-hepatitis B surface (anti-HBs) and antihepatitis B core (anti-HBc) in patients with acquired immuno-deficiency syndrome (AIDS). East Afr Med J 1990;67:355-8
29. Ahmed SD, Cuevas LE, Brabin BJ, et al. Seroprevalence of hepatitis B and C and HIV in Malawian pregnant women. J Infect 1998;37:248-51
30. Combe P, La Ruche G, Bonard D, et al. Hepatitis B and C infections, human immunodeficiency virus and other sexually transmitted infections among women of childbearing age in Côte d'Ivoire, West Africa. Trans R Soc Trop Med Hyg 2001;95:493-6
31. Sutcliffe S, Taha TE, Kumwenda NI, et al. HIV-1 prevalence and herpes simplex virus 2, hepatitis C virus, and hepatitis B virus infections among male workers at a sugar estate in Malawi. J Aquir Immune Defic Syndr 2002;31:90-7
32. Oshitani H, Kasolo FC, Mpabalwani M, et al. Prevalence of hepatitis B antigens in human immunodeficiency virus type 1 seropositive and seronegative pregnant women in Zambia. Trans R Soc Trop Med Hyg 1996;90:235-6
33. Tsebe KV, Burnett RJ, Hlungwani NP, et al. The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds. Vaccine 2001;19:3919-26
34. Hoosen AA, Seheri ML, Burnett RJ, et al. HBV infection in women with sexually transmitted infections. International Society for Sexually Transmitted Diseases 2003 ISSTDR Congress, Ottawa, Canada 2003
35. Mphahlele MJ, Lukhwareni A, Burnett RJ, Moropeng LM, Ngobeni JM. High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa. J Clin Virol 2006;35:14-20
36. South African Department Of Health. Summary Report: National HIV and syphilis sero-prevalence survey in South Africa. 2001; www.doh.gov.za/aids/docs/ sum-report.html (Accessed November 2005)
37. Dusheiko GM, Brink BA, Conradie JD, et al. Regional prevalence of hepatitis B, delta, and human immunodeficiency virus in southern Africa: a large population survey. Am J Epidemiol 1989;129:138-45
38. Prozesky OW, Szmuness W, Stevens CE, et al. Baseline epidemiological studies for a hepatitis B vaccine trial in Kangwane. S Afr Med J 1983;64:891-3
39. DiBisceglie AM, Kew MC, Dusheiko GM, et al. Prevalence of hepatitis B virus infection among black children in Soweto. BMJ (Clin Res Ed) 1986;292:1440-2